Mr. Palmin has served as our Chief Financial Officer since the completion of the 2017 merger of Opexa Therapeutics, Inc. and Acer. He has over 25 years of corporate and finance experience. From December 2013 to February 2016, Mr. Palmin served as the President, Chief Executive Officer and a director of Acer, and from February 2016 to September 2017 he served as Acer’s acting Chief Financial Officer. Prior to joining Acer, he served in a variety of roles at Novelos Therapeutics, Inc., a pharmaceutical company, including as President and director from 1998 to October 2013, Chief Executive Officer from January 2005 to October 2013 and acting Chief Financial Officer from 1998 to September 2005. Mr. Palmin has also held roles at Lehman Brothers and Morgan Stanley. He earned a B.A. in economics from Brandeis University and an M.A. in international economics and finance from the Brandeis University International Business School.